Table 1 Comparison of baseline data before PSE between the two groups

Gender

Female

Count (%)

11 (20.4%)

11 (17.7%)

0.814

Male

Count (%)

43 (79.6%)

51 (82.3%)

Etiology of cirrhosis

Hepatitis B

Count (%)

34 (62.9%)

33 (53.2%)

0.344

Hepatitis C

Count (%)

10 (18.5%)

19 (30.7%)

Alcoholic cirrhosis

Count (%)

9 (16.7%)

10 (16.1%)

Autoimmune cirrhosis

Count (%)

1 (1.9%)

0 (0.0%)

Pre-treatment ECOG

0

Count (%)

22 (40.7%)

26 (41.9%)

0.528

1

Count (%)

26 (48.2%)

25 (40.3%)

2

Count (%)

6 (11.1%)

11 (17.8%)

Pre-treatment liver function

Child A

Count (%)

35 (64.8%)

42 (67.7%)

0.739

Child B

Count (%)

19 (35.2%)

20 (32.3%)

Age (Years)

Mean ± SD

51.4 ± 9.3

50.3 ± 10.2

0.586

Pre-treatment bilirubin (μmol/L)

Mean ± SD

14.0 ± 5.1

13.9 ± 6.2

0.919

Pretreatment Albumin (g/L)

Mean ± SD

35.27 ± 3.39

34.29 ± 3.64

0.139

Pretreatment BUN (mmol/L)

Mean ± SD

5.67 ± 1.72

5.51 ± 1.47

0.608

Pretreatment Cr (μmol/L)

Mean ± SD

74.1 ± 17.6

77.7 ± 19.8

0.308

Pretreatment WBC (G/L)

Mean ± SD

1.98 ± 0.41

2.05 ± 0.56

0.491

Pretreatment RBC (T/L)

Mean ± SD

3.08 ± 0.57

2.97 ± 0.55

0.323

Pretreatment PLT (G/L)

Mean ± SD

32.74 ± 11.93

35.26 ± 12.49

0.271

Age (Years)

PSE + Hep + DEX group

0.116

PSE group

0.131

Pre-treatment bilirubin (μmol/L)

PSE + Hep + DEX group

0.356

PSE group

0.452

Pretreatment Albumin (g/L)

PSE + Hep + DEX group

0.414

PSE group

0.607

Pretreatment BUN (mmol/L)

PSE + Hep + DEX group

0.513

PSE group

0.767

Pretreatment Cr (μmol/L)

PSE + Hep + DEX group

0.247

PSE group

0.171

Pretreatment WBC (G/L)

PSE + Hep + DEX group

0.091

PSE group

0.113

Pretreatment RBC (T/L)

PSE + Hep + DEX group

0.138

PSE group

0.073

Pretreatment PLT (G/L)

PSE + Hep + DEX group

0.120

PSE group

0.077